Anschel Technology Inc.
Market SightSaver™ patented method for eliciting visual evoked potentials.
Founded upon 7 years of clinical experience and research, Anschel Technology was formed in 2011 to develop a novel medical device. Between 1000-2000 people per year develop post-operative blindness due to optic nerve ischemia during non-ocular procedures (primarily spine and cardiac surgery). There is no effective method or device to prevent this devating outcome. The SightSaver™ is a patented FDA approved device aimed at addressing this need.